HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiang Wang Selected Research

Blood Substitutes (Artificial Blood)

2/2021Treatment of common iliac vein aneurysms: case report and literature review.
9/2011In vitro kinetics of oxygen transport in erythrocyte suspension or unmodified hemoglobin solution from human and other animals.
4/2010[Research progress of blood substitutes for the treatment of hemorrhagic shock].
6/2009[Research progress in estimating parameters of blood substitute function].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiang Wang Research Topics

Disease

273Neoplasms (Cancer)
12/2022 - 10/2002
65Breast Neoplasms (Breast Cancer)
06/2022 - 12/2005
50Inflammation (Inflammations)
01/2022 - 12/2002
40Neoplasm Metastasis (Metastasis)
11/2022 - 06/2005
37Glioma (Gliomas)
04/2022 - 01/2013
30Fibrosis (Cirrhosis)
01/2022 - 12/2002
29Hepatocellular Carcinoma (Hepatoma)
01/2022 - 09/2004
28Carcinogenesis
05/2022 - 01/2013
25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 06/2011
22Infections
06/2022 - 11/2006
19Glioblastoma (Glioblastoma Multiforme)
12/2022 - 05/2011
19Adenocarcinoma of Lung
05/2022 - 05/2013
18Lung Neoplasms (Lung Cancer)
08/2022 - 05/2013
17Stomach Neoplasms (Stomach Cancer)
03/2022 - 04/2012
17Carcinoma (Carcinomatosis)
01/2022 - 11/2002
16Schizophrenia (Dementia Praecox)
01/2022 - 03/2008
15Sepsis (Septicemia)
02/2022 - 01/2015
15Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 06/2005
14Hypoxia (Hypoxemia)
01/2022 - 01/2004
14Hypertension (High Blood Pressure)
08/2021 - 05/2009
13Urinary Bladder Neoplasms (Bladder Cancer)
11/2021 - 06/2007
12Myocardial Infarction
01/2022 - 01/2004
11Pain (Aches)
04/2022 - 05/2012
11Non-alcoholic Fatty Liver Disease
01/2022 - 06/2010
11Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2009
11Prostatic Neoplasms (Prostate Cancer)
01/2022 - 11/2010
11Atherosclerosis
03/2021 - 10/2009
11Leukemia
01/2021 - 01/2010
10Thrombosis (Thrombus)
11/2022 - 06/2005
10Hypertrophy
01/2022 - 03/2005
10Stroke (Strokes)
01/2022 - 01/2016
10Colonic Neoplasms (Colon Cancer)
10/2021 - 12/2014
10Wounds and Injuries (Trauma)
08/2021 - 10/2012
10Pneumonia (Pneumonitis)
01/2021 - 07/2007
8Type 2 Diabetes Mellitus (MODY)
12/2022 - 03/2005
8Heart Failure
12/2022 - 09/2017
8Pathologic Constriction (Stenosis)
08/2022 - 07/2015
8Adenocarcinoma
03/2021 - 03/2005
8Obesity
01/2021 - 01/2005
8Cardiomegaly (Heart Hypertrophy)
01/2021 - 05/2009
7Liver Neoplasms (Liver Cancer)
03/2022 - 01/2019
7Ischemia
01/2022 - 11/2007
7Hemorrhage
01/2022 - 11/2002
7Hyperglycemia
06/2021 - 01/2007
7Body Weight (Weight, Body)
01/2021 - 04/2007
7Infarction (Infarctions)
01/2020 - 01/2004
6Kidney Calculi (Kidney Stone)
01/2022 - 01/2018
6Human Influenza (Influenza)
01/2022 - 02/2014

Drug/Important Bio-Agent (IBA)

74Proteins (Proteins, Gene)FDA Link
12/2022 - 11/2006
64Biomarkers (Surrogate Marker)IBA
08/2022 - 04/2010
41Pharmaceutical PreparationsIBA
08/2022 - 10/2008
40MicroRNAs (MicroRNA)IBA
05/2022 - 01/2011
36Long Noncoding RNAIBA
05/2022 - 05/2013
25Biological ProductsIBA
05/2022 - 03/2005
24CytokinesIBA
11/2022 - 06/2004
17Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2010
17Messenger RNA (mRNA)IBA
01/2022 - 05/2007
16DNA (Deoxyribonucleic Acid)IBA
01/2021 - 02/2013
15Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 10/2010
15RNA (Ribonucleic Acid)IBA
01/2021 - 03/2017
14Therapeutic UsesIBA
12/2022 - 04/2007
14Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2013
13VaccinesIBA
01/2022 - 08/2015
13Small Interfering RNA (siRNA)IBA
01/2020 - 09/2009
12Phosphotransferases (Kinase)IBA
12/2022 - 08/2008
12diazonaphthalenedisulfonic acid (NDS)IBA
01/2022 - 01/2015
12LigandsIBA
01/2021 - 01/2011
10EnzymesIBA
04/2022 - 10/2002
10LipidsIBA
01/2022 - 03/2012
10Protein Kinases (Protein Kinase)IBA
01/2022 - 09/2008
10Oxygen (Dioxygen)IBA
12/2021 - 05/2012
10Estrogen ReceptorsIBA
12/2021 - 01/2011
10CholesterolIBA
01/2020 - 02/2011
9Indicators and Reagents (Reagents)IBA
01/2022 - 03/2014
9Histones (Histone)IBA
01/2022 - 06/2011
9CollagenIBA
01/2022 - 07/2004
9Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020 - 04/2007
9Matrix Metalloproteinases (MMPs)IBA
11/2017 - 09/2009
8Interleukin-6 (Interleukin 6)IBA
11/2022 - 01/2018
8Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 08/2013
8CateninsIBA
01/2022 - 01/2016
8Metalloproteases (Metalloproteinases)IBA
12/2021 - 05/2009
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 01/2004
8MidkineIBA
11/2019 - 12/2006
7Cisplatin (Platino)FDA LinkGeneric
06/2022 - 04/2007
7Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 12/2007
7Triglycerides (Triacylglycerol)IBA
01/2022 - 06/2010
7NucleotidesIBA
01/2020 - 01/2014
7oxidized low density lipoproteinIBA
01/2020 - 06/2004
7NF-kappa B (NF-kB)IBA
11/2019 - 11/2009
7Antisense OligonucleotidesIBA
11/2019 - 12/2006
7Carbon Nanotubes (Carbon Nanotube)IBA
01/2017 - 10/2008
6Carboplatin (JM8)FDA LinkGeneric
01/2022 - 10/2012
6AntigensIBA
01/2022 - 12/2009

Therapy/Procedure

107Therapeutics
12/2022 - 04/2007
44Drug Therapy (Chemotherapy)
05/2022 - 11/2002
28Radiotherapy
01/2022 - 11/2002
21Immunotherapy
07/2022 - 07/2013
10Neoadjuvant Therapy
01/2022 - 10/2012
9Stents
02/2021 - 02/2014